5-Amino-1MQ: adverse events and evidence limits
In Neelakantan and colleagues’ study, 5-Amino-1MQ reduced 3T3-L1 cell viability at high concentrations after 24 hours of exposure. This is a laboratory cytotoxicity signal, not an established human adverse reaction. [1]
A separate experiment involved obese mice: nine per group, with subcutaneous administration for 11 days. That short experiment cannot establish human adverse-reaction frequencies or long-term safety. [1]
What the studies reported
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Reduced cell viability (in-vitro cytotoxicity) | 3T3-L1 cells, 24 hours of exposure | At high concentrations; a laboratory signal, not an established human adverse reaction; no frequency given | [1] |
| Adverse reactions in the animal model | Obese mice, nine animals per group, subcutaneous administration for 11 days | The short experiment did not determine adverse-reaction frequencies; long-term safety in humans is not established | [1] |
References
- Neelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ. (2018). Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice https://doi.org/10.1016/j.bcp.2017.11.007.